Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ASPAVELI 1080 MG SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ASPAVELI 1080 MG SOLUCION PARA PERFUSION

Approved

STANDARD

ASPAVELI 1080 MG SOLUCION PARA PERFUSION

Swedish Orphan Biovitrum Ab (Publ)🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Dec 30, 2021
Approval ID: 24e8dab9d6788689
Company: Swedish Orphan Biovitrum Ab (Publ)
Type: Standard

Approval Details

Approval Id: 24e8dab9d6788689
Drug Cima Aemps Name: ASPAVELI 1080 MG SOLUCION PARA PERFUSION
Register Number: 1211595001
Holder Company Name: Swedish Orphan Biovitrum Ab (Publ)
Marketing Company Name: Swedish Orphan Biovitrum S.L.
Holder Company Detail Path: /organization/swedish-orphan-biovitrum-ab-publ
Authorization Date: 2021-12-30
Dosage Form: SOLUCIÓN PARA PERFUSIÓN
Dose: 1080 mg
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Swedish Orphan Biovitrum Ab (Publ)
Company Detail Path: /organization/swedish-orphan-biovitrum-ab-publ

Company Information

Pharmaceutical Company Name: Swedish Orphan Biovitrum AB (publ)
Name En: Swedish Orphan Biovitrum AB (publ)
Country Name: Sweden
City Name: solna,stockholm,country_se
Address: Tomtebodavägen 23A
Website: https://www.sobi.com

Active Ingredients

PEGCETACOPLAN

54 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 30, 2021

Approval ID

24e8dab9d6788689

Type

Standard

Back to CIMA-AEMPS Approvals